|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/68 | |
| A61K 31/44 | |||
| A61K 39/395 | |||
| A61K 45/00 | |||
| A61K 45/06 | |||
| A61P 1/16 | |||
| A61P 35/00 | |||
| A61P 43/00 | |||
| C12Q 1/02 | |||
| G01N 33/574 | |||
| C07K 16/18 | |||
| C07K 16/46 |
| (11) | Number of the document | 3318879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16818042.0 |
| Date of filing the European patent application | 2016-06-30 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/069493 |
| Date | 2016-06-30 |
| (87) | Number | WO 2017/002934 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 2015133076 | 2015-07-01 | JP |
| (72) |
OHTOMO, Toshihiko, JP
TANAKA, Takayoshi, JP
SUGITANI, Yasuo, JP
|
| (73) |
Chugai Seiyaku Kabushiki Kaisha,
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543,
JP
|
| (54) | GPC3-TARGETING THERAPEUTIC AGENT WHICH IS ADMINISTERED TO PATIENT FOR WHOM THE GPC3-TARGETING THERAPEUTIC AGENT IS EFFECTIVE |
| GPC3-TARGETING THERAPEUTIC AGENT WHICH IS ADMINISTERED TO PATIENT FOR WHOM THE GPC3-TARGETING THERAPEUTIC AGENT IS EFFECTIVE |